[1-[2-[2-[2-[2-[4-[2,4,6-Trioxo-5-(4-phenoxyphenyl)-1,3-diazinan-5-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methyl 4-fluorobenzoate

InChIKey	`SVUOUTRIPGSFHF-UHFFFAOYSA-N`
Compound Name	[1-[2-[2-[2-[2-[4-[2,4,6-Trioxo-5-(4-phenoxyphenyl)-1,3-diazinan-5-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methyl 4-fluorobenzoate
Canonical SMILES	`O=C1NC(=O)C(c2ccc(Oc3ccccc3)cc2)(N2CCN(CCOCCOCCOCCn3cc(COC(=O)c4ccc(F)cc4)nn3)CC2)C(=O)N1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	7.83
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P45452	MMP13	Homo sapiens	Human	PF00045 PF00413 PF01471	8.2	IC50	ChEMBL;BindingDB
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	7.7	pIC50	TTD_MultiTarget
P14780	MMP9	Homo sapiens	Human	PF00040 PF00045 PF00413	7.6	IC50	ChEMBL;BindingDB
P22894	MMP8	Homo sapiens	Human	PF00045 PF00413 PF01471	7.6	IC50	ChEMBL;BindingDB
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	8.2	pIC50	TTD_MultiTarget